commitments to sustainable development commitments to sustainable development On One Health Day, Boehringer Ingelheim shares an update on its strategic approach to sustainability for employees, partners and wider communities
Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer IME launch collaboration which aims to develop sustainable animal health products
Acquisition Saint-Herblon site and Coophavet brand Acquisition Saint-Herblon site and Coophavet brand Boehringer Ingelheim and Dopharma complete the acquisition of Saint-Herblon production site
A tool to aid in the prevention of African swine fever A tool to aid in the prevention of African swine fever ASF COMBAT is an online management and biosecurity assessment tool aimed at reducing the African swine fever introduction risk level.
Boehringer Ingelheim leader in hatchery vaccination Boehringer Ingelheim leader in hatchery vaccination Boehringer Ingelheim is a leader in hatchery vaccination with vector vaccines.
Ukraine Help: We fly, we bike, we accommodate Ukraine Help: We fly, we bike, we accommodate The solidarity for Ukraine from Boehringer Ingelheim employees is incredible. Equally impressive is their practical help.
Imagine: Ecological stoves safeguard family health in Mexico Imagine: Ecological stoves safeguard family health in Mexico With Fondo Para la Paz, we’ve developed ecological stoves for safer indoor cooking, enhancing respiratory health for rural Mexican families
Survey with Ipsos to gain insights human-animal bond Survey with Ipsos to gain insights human-animal bond Boehringer Ingelheim partnered with the Ipsos Research Institute to carry out a survey to explore the human-animal bond.
Generalized pustular psoriasis (GPP): a chronic inflammatory disease Generalized pustular psoriasis (GPP): a chronic inflammatory disease Learn more about this chronic inflammatory disease associated with skin and systemic symptoms
Targeting HER2 in cancer: The story of zongertinib Targeting HER2 in cancer: The story of zongertinib We discovered zongertinib, an HER2 tyrosine kinase inhibitor, being developed as a potential oral treatment for people with HER2-mutated NSCLC
Advancing green chemistry for more sustainable medicines Advancing green chemistry for more sustainable medicines By applying the principles of eco-design and green chemistry, we developed an innovative manufacturing process with reduced environmental footprint.
Launch of Frontline flagship store on Tmall Launch of Frontline flagship store on Tmall Boehringer Ingelheim launches Frontline flagship store on Tmall to sell selling full range of pet parasiticides.
Better Access to Healthcare for Indigenous Peoples Better Access to Healthcare for Indigenous Peoples Indigenous Peoples often experience poor access to health care. Our initiatives from Canada and New Zealand aim to overcome the gap.
World Rabies Day 2020 sustainable dog vaccination World Rabies Day 2020 sustainable dog vaccination World Rabies Day 2020 sustainable dog vaccination
Living with GPP Living with GPP Video content showing a patient’s perspective of living with generalized pustular psoriasis (GPP), a rare skin condition
Big molecules - Huge potential | Bioxcellence | Boehringer Ingelheim Big molecules - Huge potential | Bioxcellence | Boehringer Ingelheim Explore the potential of big molecules with BioXcellence, offering advanced biopharmaceutical production services to unlock new possibilities in healthcare.
Exploring beyond boundaries for innovation in animal health Exploring beyond boundaries for innovation in animal health Exploring beyond boundaries by partnering with human pharma and animal health may hold the key to accelerating innovation in animal health.
More Than Scleroderma More Than Scleroderma A hub of knowledge, advice and support for those whose lives have been touched by scleroderma.
Behavioral science to improve cattle well-being Behavioral science to improve cattle well-being Boehringer Ingelheim kicks off a project based on behavioral science to improve cattle well-being
Celebrating 20 years of Metacam for cattle Celebrating 20 years of Metacam for cattle Celebrating 20 years of Metacam (Meloxicam) for cattle
T-cell engagers: Reawakening T-cells to fight cancer T-cell engagers: Reawakening T-cells to fight cancer Learn how we are taking cancer on through our approach to immuno-oncology and our T-cell engagers plarform
Groundbeaking of vaccine production center in France Groundbeaking of vaccine production center in France Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health
New vaccine against Bovine Respiratory Disease New vaccine against Bovine Respiratory Disease Boehringer Ingelheim’s Bovalto Respi Intranasal is a new respiratory vaccine for active immunization of cattle against Bovine Respiratory Disease.
Approval for Aservo EquiHaler equine asthma therapy Approval for Aservo EquiHaler equine asthma therapy Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first equine asthma therapy